SCHEMBL25010693

SCHEMBL25010693

COC[C@H](C)Oc1nc(C)ccc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.43
DHFR P00374 2/20 0.42
DCPS Q96C86 2/20 0.42
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GRM5 P41594 2/20 0.33
CDK1 P06493 1/20 0.33
CDK2 P24941 1/20 0.33
KDR P35968 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.31
TLR7 Q9NYK1 1/20 0.31
MKNK2 Q9HBH9 1/20 0.31
ABL1 P00519 2/20 0.31
ALDH1A1 P00352 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
AXL P30530 2/20 0.31
PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25010689 1.00 MCHR1 (0.43) MCHR1DHFRDCPSKDM4EUSP2
SCHEMBL30271340 1.00 MCHR1 (0.43) MCHR1DHFRDCPSKDM4EUSP2
SCHEMBL25009544 0.83 MCHR1 (0.39) MCHR1DHFRDCPSKDM4EUSP2
SCHEMBL25001065 0.83 MCHR1 (0.43) MCHR1DHFRDCPSCDK1CDK2
SCHEMBL29983687 0.79 CCNA2 (0.37) MCHR1KDM4EUSP2HPGDHSD17B10
SCHEMBL23458439 0.79 CCNA2 (0.37) MCHR1KDM4EUSP2HPGDHSD17B10
SCHEMBL29210854 0.75 CTSB (0.43) MCHR1HPGDCDK1CDK2KDR
SCHEMBL29210853 0.75 CTSB (0.43) MCHR1HPGDCDK1CDK2KDR
SCHEMBL15716080 0.75 TSHR (0.47) HSD17B10TLR7ALDH1A1SMN1; SMN2PDE10A
SCHEMBL2368572 0.74 MCHR1 (0.43) MCHR1DHFRDCPSCDK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118043041-A LPAR1 antagonists and uses thereof 康蒂内乌姆医疗公司 2024-05-14 CN disclosed
WO-2023014908-A1 LPAR1 ANTAGONISTS AND USES THEREOF Pipeline Therapeutics, Inc. (US) 2023-02-09 WO disclosed